Published in Rev Hematol on January 01, 1952
Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products. J Clin Invest (1962) 2.05
Studies on spontaneous fibrinolytic activity in patients with cirrhosis of the liver and its inhibition by epsilon amino caproic acid. Ann Surg (1961) 1.25
FIBRINOLYSIS AND CARCINOMA OF THE PROSTATE. J Clin Pathol (1965) 0.82
Defibrination Syndrome. Br Med J (1960) 0.75
Abnormal bleeding after total body perfusion. Ann R Coll Surg Engl (1961) 0.75
Acute defibrination: report of three cases. Can Med Assoc J (1955) 0.75
[Recognition of the thromboplastic state of afibrinogenemia in labor]. Arch Gynakol (1958) 0.75
Differentiation of hemophilia into two groups; a study of thirty-three cases. N Engl J Med (1953) 1.42
[Therapeutic results in the use of human serum gamma globulins; survey of 6, 602 cases. I. Main indications for their use in infections diseases]. Presse Med (1958) 1.39
[Preparation of a fraction rich in prothrombin, proconvertin, Stuart factor and antihemophilic factor B (P.P.B. fraction)]. Pathol Biol (Paris) (1959) 1.39
[Deficiency of antihemophilic factor A in a girl associated with bleeding disorder]. Rev Hematol (1953) 1.34
[Not Available]. Rev Hematol (1949) 1.25
[Differential characteristics of Hageman & P.T.A. factors; role of contact in the initial phase of coagulation]. Rev Fr Etud Clin Biol (1958) 1.21
End-to-end bronchial anastomosis after accidental division of the stem bronchus. Thorax (1951) 1.21
[Umbilical cord blood; complete study of its coaguability, comparison with maternal blood]. Etudes Neonatales (1952) 1.20
[Analytical study on Quick test; determination of prothrombin, proconvertin, and proaccelerin]. Sang (1952) 1.15
Preparation of a human plasma fraction rich in prothrombin, proconvertin, Stuart factor, and PTC and a study of its activity and toxicity in rabbits and man. J Lab Clin Med (1959) 1.14
[Not Available]. Sem Hop (1948) 1.14
Hageman trait and PTA deficiency; the role of contact of blood with glass. Br J Haematol (1959) 1.13
Measurement of thromboplastic factors and profactors in plasma. I. Deficits in thromboplastin; study of reagents; measurements of antihemophilic and of platelet activities. J Lab Clin Med (1953) 1.13
[Treatment of hemophilia B with a plasma fraction rich in antihemophilic B factor (P.P.B.)]. Pathol Biol (Paris) (1959) 1.11
[A CASE OF TRAUMATIC RUPTURE OF THE ISTHMUS OF THE THORACIC AORTA, OPERATED UPON WITH SUCCESS 8 HOURS AFTER THE ACCIDENT]. Ann Chir Thorac Cardiovasc (1964) 1.08
[Grave hemorrhages during thoracic surgery from blood incoagulability due to fibrinolysis]. Mem Acad Chir (Paris) (1951) 1.03
[Segmental pulmonary resection for bronchiectasis]. Acta Chir Belg (1950) 1.02
A new adsorption agent for coagulation factors. J Clin Pathol (1959) 1.01
[Complications of pulmonary resections for tuberculosis]. Rev Tuberc (1950) 0.96
[Electron microscope study of lymphoid leukemia with intracytoplasmic crystals]. Rev Hematol (1960) 0.96
[Determinations of properdin; technical study]. Rev Fr Etud Clin Biol (1957) 0.95
[Coarctation of aorta in infants; surgical correction]. Sem Hop (1954) 0.94
[Technical modifications of the in vitro heparin tolerance test]. Sem Hop (1951) 0.93
[Koch's bacillus in resected tuberculous lesions after chemotherapy: 97 cases]. Poumon Coeur (1955) 0.91
[Thromboplastin formation in platelet disorders; study of 34 cases by Biggs and Douglas test]. Acta Haematol (1955) 0.90
The "in vitro" heparin tolerance test in the control of dicumarol therapy. Acta Med Scand (1951) 0.90
[Willebrand-Jürgens syndrome and thrombopathies; study of 66 cases; attempt at classification]. Rev Hematol (1954) 0.90
[Heparin tolerance test in vitro in hemorrhagic syndromes and thrombosis]. Sem Hop (1950) 0.89
[Action of proteolytic enzymes on whole blood in vitro; alterations in coagulation factors and in complement]. Sem Hop (1956) 0.88
Intrathoracic neurogenic tumors in infants and children; a study of forty cases. Ann Surg (1959) 0.86
[Heparin tolerance test in vitro; hypocoagulability test, its application in diagnosis of hemorrhagic syndromes; hypercoagulability test, its application in the diagnosis of thrombosis]. Rev Hematol (1950) 0.86
[Plastic reconstruction of the bronchus for tuberculous stenosis; Gebauer's operation]. Rev Tuberc (1951) 0.86
[Physiopathology of hemorrhage in thrombocythemia; study of hemostasis in 27 patients]. Sang (1957) 0.86
[Preparation of a human plasmatic fraction rich in factor VIII (antihemophilic A) and poor in fibrinogen]. Nouv Rev Fr Hematol (1962) 0.86
[Surgery of primary tumors of the trachea]. Bronches (1961) 0.86
[Pathological variations of complement and properdin in man]. Acta Haematol (1959) 0.85
[Fatal hemorrhagic syndromes with total incoagulability by defibrination and with fibrinolysis following abortion by injection of Javelle water; problem of defibrination in obstetrics and gynecology]. Rev Hematol (1952) 0.85
[New data on the Hageman and P.T.A. factors and on the "contact"]. Rev Fr Etud Clin Biol (1959) 0.85
[New diagnostic method in hemophilia; determination of antihemophilic factors A and B]. Sang (1953) 0.84
[Hemodynamic balance of surgical pleuropulmonary diseases. Their preoperative interest]. Poumon Coeur (1960) 0.83
Tracheal diverticulum and congenital oesophagotracheal fistula without oesophageal atresia. Thorax (1954) 0.83
[Congenital communications between the coronary arteries and cardiac cavities]. Arch Mal Coeur Vaiss (1963) 0.82
[Alteration of coagulation factors in fibrinolysis in vivo; value of proaccelerin deficiency in diagnosis of defaced or latent proteolysis]. Sem Hop (1956) 0.82
[Hemorrhagic syndrome with fibrinolysis associated with cancer of the prostate]. Presse Med (1955) 0.81
[Interauricular communications (I.A.C.) with abnormal pulmonary venous return]. Ann Chir (1960) 0.81
[A new adsorbant for coagulation factors: bentonite]. Rev Hematol (1959) 0.81
[CONGENITAL DEFICIENCY OF THE FIBRIN STABILIZING FACTOR (FACTOR XIII). STUDY OF 2 CASES]. Nouv Rev Fr Hematol (1964) 0.81
[Biological study of two cases of congenital afibrinogenemia]. Rev Hematol (1955) 0.80
[Treatment of esophagothoracic fistulas. (Fistulas after esophageal resections. neoplastic fistulas and neonatal fistulas excepted)]. J Chir (Paris) (1960) 0.80
[Hemodynamic study of 10 cases of aortic coarctation during and after surgery by direct recording of intra-arterial pressures (intra-aortic, intra-femoral and intra-humeral)]. Arch Mal Coeur Vaiss (1957) 0.80
[Cerebral behavior during deep hypothermia]. Ann Chir Thorac Cardiovasc (1962) 0.80
[A case of congenital hypoconvertinemia]. Sang (1955) 0.80
The effect of intravenous injection of trypsin inhibitor on the coagulation of blood. Blood (1948) 0.79
[Congenital proaccelerin deficiency (factor V); various new data]. Thromb Diath Haemorrh (1958) 0.79
[Ductus arteriosus with pulmonary hypertension without inversion of shunt]. Arch Mal Coeur Vaiss (1955) 0.79
[Two cases (surgical and obstetric) of coagulation disorders caused by absence of circulating fibrinogen]. Rev Hematol (1954) 0.79
[Electrophoretic study of 86 cases of proteinuria (albuminuria); proteinuria in myeloma and nephropathy]. Presse Med (1953) 0.79
[Congenital arteriovenous fistulas of an extremity. (Critique of paraclinical examinations)]. Presse Med (1962) 0.78
[Half-life of true prothrombin (factor II)]. Nouv Rev Fr Hematol (1963) 0.78
[Not Available]. Sang (1954) 0.78
[Surgery in localized pulmonary emphysema in infant and child]. Arch Fr Pediatr (1956) 0.78
[Test of platelet-activity of the serum]. Rev Fr Etud Clin Biol (1957) 0.78
[Not Available]. Mem Acad Chir (Paris) (1956) 0.77
Study of prothrombin consumption; practical interest for the diagnosis of hemorrhagic diseases; study of 89 cases. Acta Med Scand (1950) 0.77
[Antihemophilic B factor deficiency with prolongation of bleeding time]. Sang (1957) 0.77
[Hageman factor deficiency]. Sang (1957) 0.77
[Surgery of primary tumors of the trachea]. Ann Chir (1960) 0.77
[Separation of fibrinogen and of the antihemophilic factor A]. Rev Hematol (1958) 0.77
Inhibitors of blood coagulation. 4. Natural inhibitors. Thromb Diath Haemorrh (1962) 0.76
[Study of a case of congenital hypoprothrombinemia]. Nouv Rev Fr Hematol (1963) 0.76
[Not Available]. Bull Mem Soc Med Hop Paris (1955) 0.75
[Use of injectable fibrinogen in therapy]. Sem Hop (1956) 0.75
[Not Available]. Sem Hop (1948) 0.75
[Study of lipoproteins in human and experimental arteriosclerosis by electrophoresis and non-specific reactions of proteins; effect of heparin]. Sem Hop (1953) 0.75
[On hematological examination during pregnancy]. Concours Med (1951) 0.75
[A constitutional hemorrhagic disease characterized by isolated prolongation of the bleeding time (Willebrand's disease; study of 9 cases)]. Rev Hematol (1950) 0.75
[Disorders of the blood composition in acute leukemias; biological and therapeutic study]. Sang (1950) 0.75
[Anticoagulants]. Rev Pathol Comp (1952) 0.75
[Not Available]. Prog Med (Paris) (1948) 0.75
[Vascular fragility and production of estroids by adrenal cortex in children]. Sem Hop (1954) 0.75
[Not Available]. Rev Fr Etud Clin Biol (1956) 0.75
[Necessity of a laboratory]. Concours Med (1950) 0.75
[Heparin tolerance test in vitro; its technique its clinical interest]. Ann Biol Clin (Paris) (1952) 0.75
[Hypoprothrombinemia secondary to dicoumarin therapy; shock due to prolonged vitamin K2 therapy and perfusions and spectacular cure with vitamin K1]. Sang (1952) 0.75
[Value of anticoagulants in the treatment of pulmonary emboli]. Presse Med (1957) 0.75
[The physiology of hemostasis and the large hemorrhagic syndromes]. Rev Fr Odontostomatol (1953) 0.75
[Not Available]. Ann Biol Clin (Paris) (1949) 0.75
[A new case of congenital thrombocytic hemorrhagic dystrophy]. Presse Med (1952) 0.75
[Physiopathology of hemorrhages]. Presse Med (1950) 0.75
[Not Available]. Paris Med (1950) 0.75
[Not Available]. Bull Mem Soc Med Paris (1907) (1950) 0.75
[Appearance of an antithrombin following thrombin injections in a hemophilic having presented a circulating anticoagulant]. Rev Hematol (1953) 0.75
[Circulating anticoagulant of antithromboplastic activity]. Rev Fr Etud Clin Biol (1956) 0.75
[Attempted electrophoretic identification of resorcidine]. Sang (1952) 0.75
[Hypercoagulability]. Rev Fr Etud Clin Biol (1956) 0.75
[Not Available]. Presse Med (1949) 0.75
[Complete failure of vitamin B12 in a case of familial hemophilia]. Rev Hematol (1953) 0.75